ANTIBODIES

Contributor Information
- Name Ayham Alnabulsi
- Institute Vertebrate Antibodies Limited
Tool Details
- Tool name: Anti-LRAT [M34-P1F10]
- Clone: M34-P1F10
- Tool type: Antibodies
- Tool sub-type: Primary antibody
- Class: Monoclonal
- Conjugate: Unconjugated
- Reactivity: Human
- Host: Mouse
- Cancer type: Digestive / Gastrointestinal cancer
- Application: ELISA ; IHC ; IF ; WB
- Strain: Balb/c
- Description: LRAT is significantly overexpressed in colorectal cancer and significantly associated with prognosis.
- Immunogen: Peptide Sequence - RDQRSVLASA (amino acids 190 -199)
- Isotype: IgG1
- Research area: Cell signaling and signal transduction; Metabolism; Neurobiology
- For Research Use Only
Target Details
- Target: Lecithin Retinol Acyltransferase (LRAT)
- Target background: LRAT is significantly overexpressed in colorectal cancer and significantly associated with prognosis.
Application Details
- Application: ELISA ; IHC ; IF ; WB
Handling
- Format: Liquid
- Concentration: 1 mg/ml
- Storage buffer: PBS with 0.02% azide
- Storage conditions: -15ðC to -25ðC
- Shipping conditions: Shipping at 4ðC
Related Tools
References
- • Brown et al. 2014. PLoS One. 9(3):e90776. PMID: 24608339.
- • The expression and prognostic significance of retinoic acid metabolising enzymes in colorectal cancer.